185 related articles for article (PubMed ID: 23643657)
1. When restless legs syndrome turns malignant.
Schulte EC; Gross N; Slawik H; Winkelmann J
Sleep Med; 2013 Jun; 14(6):575-7. PubMed ID: 23643657
[TBL] [Abstract][Full Text] [Related]
2. "Malignant restless legs syndrome"--a curse or a blessing?
Schulte EC; Gross N; Slawik H; Winkelmann J
Sleep Med; 2014 Jan; 15(1):155-6. PubMed ID: 24325808
[No Abstract] [Full Text] [Related]
3. "Malignant" restless legs syndrome. Are we being too harsh with the name?
Ganguly G
Sleep Med; 2014 Jan; 15(1):155. PubMed ID: 24325807
[No Abstract] [Full Text] [Related]
4. Current guidelines and standards of practice for restless legs syndrome.
Hening WA
Am J Med; 2007 Jan; 120(1 Suppl 1):S22-7. PubMed ID: 17198767
[TBL] [Abstract][Full Text] [Related]
5. Opioids in the treatment of restless legs syndrome: pharmacological and clinical aspects.
de Biase S; Merlino G; Valente M; Gigli GL
Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1035-45. PubMed ID: 27310338
[TBL] [Abstract][Full Text] [Related]
6. Transient restless legs-like syndrome as a complication of opiate withrawal.
Scherbaum N; Stüper B; Bonnet U; Gastpar M
Pharmacopsychiatry; 2003; 36(2):70-2. PubMed ID: 12734764
[TBL] [Abstract][Full Text] [Related]
7. Methadone for refractory restless legs syndrome.
Ondo WG
Mov Disord; 2005 Mar; 20(3):345-8. PubMed ID: 15580610
[TBL] [Abstract][Full Text] [Related]
8. [Restless legs syndrome in patients on dialysis for kidney insufficiency: effect of medication].
Hohl-Radke F; Aedtner F; Domröse U; Neumann KH; Staedt J
Dtsch Med Wochenschr; 2008 Jan; 133(3):71-5. PubMed ID: 18186007
[TBL] [Abstract][Full Text] [Related]
9. [Restless legs: recent advances in basic research and therapy].
Sieb JP
Med Monatsschr Pharm; 2010 Apr; 33(4):133-9. PubMed ID: 20429403
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic augmentation of restless legs syndrome.
García-Borreguero D; Williams AM
Sleep Med Rev; 2010 Oct; 14(5):339-46. PubMed ID: 20219397
[TBL] [Abstract][Full Text] [Related]
11. [Restless-legs syndrome].
Karroum E; Konofal E; Arnulf I
Rev Neurol (Paris); 2008; 164(8-9):701-21. PubMed ID: 18656214
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
[TBL] [Abstract][Full Text] [Related]
13. Changes of cortical excitability after dopaminergic treatment in restless legs syndrome.
Scalise A; Pittaro-Cadore I; Janes F; Marinig R; Gigli GL
Sleep Med; 2010 Jan; 11(1):75-81. PubMed ID: 19595629
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients.
Enomoto M; Inoue Y; Namba K; Munezawa T; Matsuura M
Mov Disord; 2008 Apr; 23(6):811-6; quiz 926. PubMed ID: 18074382
[TBL] [Abstract][Full Text] [Related]
15. THE RESTLESS LEGS SYNDROME (REVIEW).
Japaridze G; Kasradze S; Maisuradze L; Popp R; Wetter T
Georgian Med News; 2018 Dec; (285):74-81. PubMed ID: 30702074
[TBL] [Abstract][Full Text] [Related]
16. Sensory symptoms in restless legs syndrome: the enigma of pain.
Winkelman JW; Gagnon A; Clair AG
Sleep Med; 2013 Oct; 14(10):934-42. PubMed ID: 23948222
[TBL] [Abstract][Full Text] [Related]
17. Long-Term treatment of a patient with severe restless legs syndrome using intrathecal morphine.
Hornyak M; Kaube H
Neurology; 2012 Dec; 79(24):2361-2. PubMed ID: 23197746
[TBL] [Abstract][Full Text] [Related]
18. Restless legs syndrome (RLS) with expansion of symptoms to the face.
Buchfuhrer MJ
Sleep Med; 2008 Jan; 9(2):188-90. PubMed ID: 17638589
[TBL] [Abstract][Full Text] [Related]
19. Unilateral RLS with predominantly ipsilateral PLMS and variable response to dopaminergic drugs: a variant of idiopathic RLS?
Valko PO; Siccoli MM; Bassetti CL
Eur J Neurol; 2009 Mar; 16(3):430-2. PubMed ID: 19175379
[TBL] [Abstract][Full Text] [Related]
20. Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome.
Wanner V; Garcia Malo C; Romero S; Cano-Pumarega I; García-Borreguero D
Adv Pharmacol; 2019; 84():187-205. PubMed ID: 31229171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
